Your browser doesn't support javascript.
loading
A retrospective study of the efficacy of combined EGFR­TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR­TKI monotherapy for PD­L1­positive EGFR­mutant non­small cell lung cancer: North Japan Lung Cancer Study Group 2202.
Inomata, Minehiko; Kawashima, Yosuke; Saito, Ryota; Morinaga, Daisuke; Nogawa, Hitomi; Sato, Masamichi; Suzuki, Yohei; Yanagisawa, Satoru; Kikuchi, Takashi; Jingu, Daisuke; Yoshimura, Naruo; Harada, Toshiyuki; Miyauchi, Eisaku.
Affiliation
  • Inomata M; First Department of Internal Medicine, Toyama University Hospital, Toyama 930-0194, Japan.
  • Kawashima Y; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Miyagi 980-0873, Japan.
  • Saito R; Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Miyagi 980-8574, Japan.
  • Morinaga D; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido 060-8648, Japan.
  • Nogawa H; Department of Respiratory Medicine, Yamagata Prefectural Central Hospital, Yamagata 990-2292, Japan.
  • Sato M; Department of Cardiology, Pulmonology, and Nephrology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan.
  • Suzuki Y; Department of Thoracic Surgery, Omagari Kosei Medical Center, Daisen, Akita 014-0027, Japan.
  • Yanagisawa S; Department of Respiratory Medicine, Saku Central Hospital Advanced Care Center, Saku, Nagano 385-0051, Japan.
  • Kikuchi T; Department of Respiratory Medicine, Iwate Prefectural Isawa Hospital, Ohshu, Iwate 023-0864, Japan.
  • Jingu D; Department of Respiratory Medicine, Saka General Hospital, Shiogama, Miyagi 985-8506, Japan.
  • Yoshimura N; Department of Respiratory Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8512, Japan.
  • Harada T; Department of Respiratory Medicine, Japan Community Health Care Organization Hokkaido Hospital, Sapporo, Hokkaido 062-0921, Japan.
  • Miyauchi E; Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Miyagi 980-8574, Japan.
Oncol Lett ; 26(2): 334, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37427337

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Oncol Lett Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Grecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Oncol Lett Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Grecia